TheraRadar
← Back
Data updated: Jun 28, 2026

SOMERSET THERAP

Generics
Pharmaceuticals

SOMERSET THERAP is a generic drug manufacturer with 1 FDA-approved products.

2025
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

SOMERSET THERAP's Key Drugs

SOMERSET THERAP's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

SOMERSET THERAP's Recent FDA Approvals

New NDA/BLA approvals for SOMERSET THERAP over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

SOMERSET THERAP's Therapeutic Areas

Disease areas where SOMERSET THERAP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

SOMERSET THERAP Pipeline Snapshot

Active clinical trials for SOMERSET THERAP across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling